Rosseli D, Rueda J, Wolowacz SE, Brockbank JA, Abeysinghe SS. Cost-effectiveness of dabigatran compared with warfarin, apixaban, rivaroxaban and low molecular weight heparins for the treatment and secondary prevention of venous thromboembolism in Colombia. Poster presented at the 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research; November 2014. Amsterdam, The Netherlands.

Abstract not available at this time

Share on: